• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer

byJayden BerdugoandAlex Chan
August 27, 2025
in Chronic Disease, Oncology
Reading Time: 2 mins read
Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer
Share on FacebookShare on TwitterShare on LinkedIn

1. In this Australian cohort of adults, individuals diagnosed with cancer experienced greater declines in physical functioning and slightly higher psychological distress compared to people without cancer

2. This finding was especially pronounced among those with advanced disease or recent treatment. 

Evidence Rating Level: 1 (Excellent) 

Cancer survival rates are improving worldwide due to better early detection and treatment. In Australia, the 5-year survival rate for all cancers rose from 50.2% in 1989-1993 to 70.6% in 2015-2019. While cancer survivors are generally more likely to experience physical limitations and mild psychological distress, outcomes vary widely by cancer type, stage, and treatment status. Previous research has been limited by short follow-up periods, a focus on single cancer types, and a lack of pre-diagnosis data or control groups without cancer. This study addresses those gaps by using large-scale, population-based data to compare physical and psychological changes from before to after cancer diagnosis with matched changes in people without cancer. After removing ineligible individuals who had cancer at baseline, the main focus was on those who were newly diagnosed with cancer between the first and follow-up surveys. The primary outcomes were how much physical limitations (assessed using the Medical Outcomes Study Physical Functioning [MOS-PF] score) and psychological distress (assessed using the Kessler-10 [K10]) changed between baseline to follow-up. After meeting eligibility criteria, 142,682 participants were included in the study. Over 5.2 years, 9,313 participants were diagnosed with cancer while 133,369 were not. Participants diagnosed with cancer experienced a greater deterioration in physical function over time compared to those without cancer (40.6% vs. 52.3%). Compared to people without cancer, cancer survivors had larger declines in physical functioning (average follow-up score: 77.5 vs 82.9; average change: -8.31 vs -4.71; adjusted difference -2.55, 95% CI: -2.97 to -2.13) and slightly more psychological distress (average follow-up score: 13.6 versus 13.5 at follow-up; mean-change: 0.24 versus − 0.04; adjusted-difference 0.21 (95%CI = 0.12–0.31)). Physical health declined more for people with multiple myeloma, lung cancer, and leukemia, and less for those with breast, colorectal, or prostate cancer. Survivors with advanced disease or those still undergoing treatment experienced greater declines in physical and psychological well-being. However, psychological well-being was similar between cancer-free individuals and survivors who were not receiving treatment at follow-up. In conclusion, participants newly diagnosed with cancer experienced a significantly greater decline in physical function and slightly decreased psychological well-being compared to participants without cancer. 

Click to read the study in BMC Medicine

Image: PD

RELATED REPORTS

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancerchronic diseasemedical oncologyoncologypsychiatry
Previous Post

Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea

Next Post

Artificial Intelligence Model Matches Patients to Clinical Trials with Near Human Accuracy

RelatedReports

A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
A liver illustration with spilled sugar cubes and two drink cups, highlighting the link between sugary drinks and liver health.
Chronic Disease

Male sex is associated with higher mortality among patients with hepatocellular carcinoma

October 7, 2026
An illustration featuring a stomach, DNA helix, and a close-up of Helicobacter pylori bacteria, highlighting genetic susceptibility to gastric conditions.
Artificial Intelligence

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

October 16, 2026
A collage illustrating the urinary bladder, immune system elements, cancer cells, and an IV bag, highlighting immunotherapy for urothelial cancer.
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Next Post
Anaerobic antibiotics may decrease mortality in infants with necrotizing enterocolitis

Artificial Intelligence Model Matches Patients to Clinical Trials with Near Human Accuracy

Increased number of daily steps linked with decreased mortality in older women

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Pulsed field ablation noninferior to cryoablation for reducing paroxysmal atrial fibrillation recurrence

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.